One study suggests that positive associations between IGF1 concentrations and breast cancer risk may be restricted to ER+ tumors (9), which may explain why stronger associations were observed for ER+ and/or PgR+ tumors in our study. This evidence concerns the gene PGR and breast carcinoma.